Skip to content

A randomized controlled study on the treatment of androgen alopecia caused by spleen deficiency and dampness in combination with Qushi Jianfa Decoction for internal administration.

A randomized controlled study on the treatment of androgen alopecia caused by spleen deficiency and dampness in combination with Qushi Jianfa Decoction for internal administration.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000172
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-08
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia

Interventions

Integrated treatment group:Oral Qushi Jianfa Decoction combined with the prescription wash of Deep-bone Grass
Qudampness Jianfa decoction group:Oral Qushi Jianfa decoction

Sponsors

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-50 years old (including 18 and 50 years old) is not limited to men and women 2) Meet the AGA diagnostic criteria and syndrome diagnosis criteria of "Chinese Androgenic Alopecia Diagnosis and Treatment Guide"; 3) The severity of hair loss: in line with the Hamilton scale of IIa-III stage; 4) Agree to present the hair of the observation site and temporarily dye the spot hair; 5) Voluntarily participate in this study, can adhere to medication and follow-up, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Serious heart, liver, kidney, mental diseases and other skin diseases; 2) Received systemic treatment and local treatment for hair loss within 3 months; 3) Abnormal results of laboratory tests (blood routine, urine routine, liver and kidney function) during the screening period and judged by doctors to be clinically significant; 4) Those who do not agree to maintain hair style and hair color during the test; 5) had previously undergone hair transplant surgery, scalp reconstruction, or scalp tattooing; 6) Use or have used hair removal drugs, laser hair removal, use wax on the scalp; 7) Scalp with seborrheic dermatitis, bald folliculitis, alopecia areata; 8) Diseases that researchers believe may affect hair growth, such as immune deficiency, connective tissue-related diseases, or infectious alopecia; 9) Patients with small scalp and hair color contrast, such as too light skin or too white hair; 10) For other conditions that the investigator deems inappropriate to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Scalp oil;Hair number;

Secondary

MeasureTime frame
Scalp itch degree;Hair diameter;Hair folliculitis of the scalp;Dandruff condition;

Countries

China

Contacts

Public ContactWeiwen Chen

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

chenweiwen@bjzhongyi.com18519866309

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026